Navigation Links
Ionian Technologies, Inc. Signs Molecular Diagnostic Manufacturing Agreement With Roche Diagnostics
Date:11/12/2009

SAN DIEGO, Nov. 12 /PRNewswire/ -- Ionian Technologies, Inc. and Roche Diagnostics Corporation have entered into a collaborative agreement based on Ionian's rapid isothermal nucleic acid amplification technology. Under this agreement, Roche will identify new applications and customers for the technology and will bring these opportunities to Ionian. Roche will have exclusive manufacturing rights for these specific opportunities upon commercialization.

"We are excited by this collaboration as it allows Ionian to continue to focus on its core strengths, including technology and assay development, while leveraging the business development, sales, and manufacturing expertise of Roche, a worldwide leader in healthcare and diagnostics," said Andrew P. Miller, Chief Executive Officer of Ionian Technologies, Inc.

Ionian's isothermal amplification technology, the NEAR Assay(TM) provides for detection of both DNA and RNA from bacterial or viral pathogens in less than 10 minutes. Furthermore, the technology is amenable to raw or unpurified samples, obviating the need for complex sample processing and purification steps. Based on these key attributes, Ionian's technology is ideally suited for point-of-care and point-of-use settings.

Founded in 2000, Ionian Technologies, Inc. is focused on commercializing its proprietary technology for the rapid detection of nucleic acids in various fields, including human in vitro diagnostics, food safety, biodefense, agriculture, and veterinary applications. Ionian is privately held and is based in San Diego, CA.

    For more information, contact -
    Ionian Technologies, Inc.
    Andrew P. Miller, Ph.D.
    Chief Executive Officer
    858-642-0998, ext. 220

SOURCE Ionian Technologies, Inc.


'/>"/>
SOURCE Ionian Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
3. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
4. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
5. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
6. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
7. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
8. Wound Management Technologies, Inc. Announces Evidence Based Study
9. OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
10. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
11. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
(Date:9/12/2017)... -- Consumer reviews on the independent review site Consumer Affairs ... for hearing aids, ranking it higher than Miracle Ear ™, ... ... Hearing Aids ... store that provides high performance, state-of-the-art, German-engineered hearing aids directly to ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, a leading ... Denise Flannery, to its strategic advisory and client development team. , In ... with clients across different industries to develop and implement market-justified strategies, modernize and ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... has joined its executive team as the President of its HealthBI division. ... management systems and contact centers. , “Scott is a utility player who ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has introduced ... When we’re born, Nature gives us a full supply of melanin – in ... continuously lose this natural glare-reducing pigment; however, around the age of thirty, we develop ...
(Date:9/19/2017)... ... September 19, 2017 , ... Bringing ... the MirixaPro 6.0 platform. As the industry’s leading Medication Therapy Management solution, ... Based on industry research and market feedback, the latest version of MirixaPro ...
(Date:9/19/2017)... ... 2017 , ... Back Pain Centers of America ... with a reputable physician in their area, announces the addition of Allegion Spine ... Spine Clinic was founded by board-certified spine surgeon, Jaswinder Grover, M.D. , ...
Breaking Medicine News(10 mins):